Maitake and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Maitake (maitake mushroom), especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months also take Vitamin D3, and have Pain.

The phase IV clinical study analyzes which people have Weakness when taking Maitake. It is created by eHealthMe based on reports of 34 people who have side effects when taking Maitake from the FDA, and is updated regularly.

What is Maitake?

Maitake has active ingredients of maitake mushroom. eHealthMe is studying from 41 Maitake users. Check the latest studies of Maitake.

What is Weakness?

Weakness is found to be associated with 3,639 drugs and 6,577 conditions by eHealthMe. Check the latest studies of Weakness.

On Feb, 12, 2026

34 people reported to have side effects when taking Maitake.
Among them, 9 people (26.47%) have Weakness.

Among these 9 people:

How long have people been on Maitake when they have Weakness? *

What is the gender of people who have Weakness when taking Maitake? *

female: 66.67 %
male: 33.33 %

What is the age of people who have Weakness when taking Maitake? *

What are other drugs people take besides Maitake? *

What are other side effects people have besides Weakness? *

Fatigue (feeling of tiredness): 5 people, 55.56%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 44.44%
Pain: 3 people, 33.33%
Weight Decreased: 3 people, 33.33%
Fall: 3 people, 33.33%
Inflammation: 3 people, 33.33%
High Blood Pressure: 3 people, 33.33%
Pain In Extremity: 3 people, 33.33%
Memory Loss: 3 people, 33.33%
Drowsiness: 2 people, 22.22%

What are the existing conditions these people have? *

Constipation: 3 people, 33.33%
Pain: 3 people, 33.33%
Urinary Tract Infection: 2 people, 22.22%
Muscle Spasms (muscle contraction): 2 people, 22.22%
Glaucoma (increased fluid pressure in the eye with vision loss): 2 people, 22.22%
Hyperlipidaemia (presence of excess lipids in the blood): 2 people, 22.22%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 2 people, 22.22%
Back Pain: 2 people, 22.22%
Nausea (feeling of having an urge to vomit): 2 people, 22.22%
Nausea And Vomiting: 2 people, 22.22%

* Approximation only. Some reports may have incomplete information.

Do you take Maitake and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Maitake:

Maitake (41 reports)

Weakness treatments and more:

Weakness (586,869 reports)

Browse all side effects of Maitake:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,639 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,577 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on maitake mushroom (the active ingredients of Maitake) and Maitake (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.